Is Moderna (MRNA) a buy, sell, or hold in 2025? In this episode of Is the Bottom In?, we break down the biotech giant’s post-pandemic challenges, revenue projections, and technical chart signals. With COVID-19 vaccine sales declining and new respiratory vaccines entering the mix, we explore three scenarios—Bull, Base, and Bear—and reveal our fair value estimates.
📉 Bear Case: $7.71 📊 Base Case: $23.23 🚀 Bull Case: $35.97 🎯 Weighted Fair Value: water main break auburn hills ~$20.98
We also analyze key support levels and why a break below $24 could send the stock tumbling toward $14. Don’t miss this data-driven breakdown!
Moderna stock analysis 2025
Is Moderna a santo del giorno buy now
MRNA stock forecast
Moderna technical chart breakdown
Biotech investing post-COVID
Moderna vaccine revenue decline
MRNA support and resistance levels
Should I buy directive 8020 Moderna stock
Moderna fair value estimate
MRNA bear case vs bull case
🔔 Like, subscribe, and hit the bell for more stock deep dives. 💬 Drop your thoughts in the comments: Is the bottom in for Moderna?
Disclaimer: This is not financial advice. Always do your own research.
